À̽ÂÇö ¸íÀÇ

Æó¾Ï Ä¡·áÀÇ Çõ½ÅÀ» À̲ô´Â ¼±±¸ÀÚ

À̽ÂÇö ¸íÀÇ

  • ¼Ò ¼Ó
    °æÈñ´ëÇб³º´¿ø
  • Áø·á°ú
    È£Èí±â³»°ú
  • Àü¹®ºÐ¾ß
    Æó¾Ï, °£Áú¼ºÆóÁúȯ, ¸¸¼º±âµµÁúȯ

Æó¾Ï Áø´Ü ¹× Ä¡·á ºÐ¾ßÀÇ ±ÇÀ§ÀÚ·Î ¼Õ²ÅÈ÷´Â À̽ÂÇö ±³¼ö´Â ÃֽŠǥÀû ¹× ¸é¿ªÄ¡·á¹ý Àû¿ë¿¡¼­ Ź¿ùÇÑ ¼º°ú¸¦ º¸À̰í ÀÖ´Ù. Æó¾Ï Á¶±âÁø´ÜÀ» À§ÇÑ ¹ÙÀÌ¿À¸¶Ä¿ ¿¬±¸¿¡ ÁÖ·ÂÇϸç, ȯÀÚ ¸ÂÃãÇü Ä¡·á °³¹ß¿¡ ±â¿©Çϰí ÀÖ´Ù. ´ÙÇÐÁ¦Àû Á¢±ÙÀ» ÅëÇØ Æó¾Ï ȯÀÚÀÇ »ýÁ¸À² Çâ»ó¿¡ Èû¾²°í ÀÖÀ¸¸ç, ±¹³»¿Ü ÇмúȰµ¿À» ÅëÇØ È£Èí±â ÀÇÇÐ ¹ßÀüÀ» ¼±µµÇϰí ÀÖ´Ù.

¸íÀÇÇÁ·ÎÇÊ ¸íÀÇ ÇÁ·ÎÇÊ

ÇзÂ

Educational Background
  • °í·Á´ë ÀÇ´ë Çлç
  • °í·Á´ë ÀÇ´ë ¼®»ç
  • °í·Á´ë ÀÇ´ë ¹Ú»ç

ÁÖ¿ä°æ·Â

Work Experience
  • úÞ) °æÈñ´ëÇб³º´¿ø È£Èí±â³»°ú ±³¼ö

¼ö»ó³»¿ª

Awards List
  • KALC International Conference Best Presentation Award
  • ´ëÇѰáÇÙ ¹× È£Èí±âÇÐȸ ¿ì¼öÃÊ·Ï»ó
  • ´ëÇÑÆó¾ÏÇÐȸ Çмú»ó

ÇÐȸȰµ¿

Academic activities
  • ´ëÇÑ Æó¾ÏÇÐȸ ÆòÀÇ¿ø
  • European Society for Medical Oncology (ESMO) member
  • Asian Pacific Society of Respirology (APSR) member
  • ´ëÇÑ °áÇÙ ¹× È£Èí±âÇÐȸ ±âȹÀ§¿ø
  • ´ëÇÑ ³»°úÇÐȸ ±³À°À§¿ø
Àú¼­ ¾ÆÀÌÄÜ

ÁýÇÊÀú¼­

ÃÑ 0°Ç
¿¬±¸ ¾ÆÀÌÄÜ

ÁÖ¿ä³í¹®

ÃÑ 7°Ç
Á¦ ¸ñ Capmatinib in MET Exon 14 Skipping Mutation-Positive Lung Adenocarcinoma with Extensive Central Nervous System Metastasis
¹ßÇ¥³âµµ 2022³â ¹ßÇ¥Áö
Á¦ ¸ñ High Tumor Mutation Burden Is Associated with Poor Clinical Outcome in EGFR-Mutated Lung Adenocarcinomas Treated with Targeted Therapy
¹ßÇ¥³âµµ 2022³â ¹ßÇ¥Áö
Á¦ ¸ñ A Study on the Perception of Concurrent Use of Western and Korean Medicine Care and Integrated Medical Service in Korea - Targeting tertiary hospital users
¹ßÇ¥³âµµ 2022³â ¹ßÇ¥Áö
Á¦ ¸ñ Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG)
¹ßÇ¥³âµµ 2022³â ¹ßÇ¥Áö
Á¦ ¸ñ Overexpression of Reactive Oxygen Species Modulator 1 Predicts Unfavorable Clinical Outcome in EGFR-Mutant Lung Adenocarcinomas Treated With Targeted Therapy
¹ßÇ¥³âµµ 2021³â ¹ßÇ¥Áö
Á¦ ¸ñ Metataxonomic investigation of the microbial community in the trachea and oropharynx of healthy controls and diabetic patients using endotracheal tubes
¹ßÇ¥³âµµ 2021³â ¹ßÇ¥Áö
Á¦ ¸ñ Serum Reactive Oxygen Species Modulator 1 as a Novel Predictive Biomarker for Resected Lung Adenocarcinoma: A Retrospective Pilot Study
¹ßÇ¥³âµµ 2021³â ¹ßÇ¥Áö

¸íÀÇqna ¸íÀÇ ¼Ò¼Óº´¿ø

°æÈñ´ëÇб³º´¿ø

»ó±ÞÁ¾ÇÕº´¿ø
ÀüÈ­ ¾ÆÀÌÄÜ ´ëÇ¥¹øÈ£
02-958-8114
À¥»çÀÌÆ® ¾ÆÀÌÄÜȨÆäÀÌÁö

ÁÖ¿ä½Ã¼³

ÀÀ±Þ½Ç ÀÀ±Þ½Ç
Ŭ¸®´Ð Ŭ¸®´Ð
Á¾ÇÕ°ËÁø¼¾ÅÍ Á¾ÇÕ°ËÁø¼¾ÅÍ
¾Ï¼¾ÅÍ ¾Ï¼¾ÅÍ
ÁÖÂ÷½Ã¼³ ÁÖÂ÷½Ã¼³

°æÈñ´ëÇб³º´¿øÀº ȯÀÚ Áß½ÉÀÇ ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇϸç, ±¹³» ÀÇ·á°è¸¦ ¼±µµÇÏ´Â »ó±ÞÁ¾ÇÕº´¿øÀÔ´Ï´Ù. ÃֽŠÀÇ·á ±â¼ú°ú Àåºñ¸¦ Ȱ¿ëÇÏ¿© ȯÀڵ鿡°Ô ÃÖ»óÀÇ Ä¡·á¸¦ Á¦°øÇÕ´Ï´Ù. ƯÈ÷ ÁßÁõÁúȯ Ä¡·á ¹× ¿¬±¸¿¡ °­Á¡À» º¸À̸ç, ´ÙÇÐÁ¦ ÇùÁø ½Ã½ºÅÛÀ» ÅëÇØ ȯÀÚÀÇ °Ç°­À» ÃÖ¿ì¼±À¸·Î »ý°¢ÇÕ´Ï´Ù. °æÈñ´ëÇб³º´¿øÀº ȯÀÚµéÀÇ ½Å·Ú¿Í ¸¸Á·µµ¸¦ ³ôÀÌ´Â µ¥ ÁÖ·ÂÇϸç, Áö¼ÓÀûÀ¸·Î ÀÇ·á ǰÁú Çâ»ó°ú ¿¬±¸ °³¹ß¿¡ Èû¾²°í ÀÖ½À´Ï´Ù.

°æÈñ´ëÇб³º´¿ø À̹ÌÁö

¼­¿ïƯº°½Ã µ¿´ë¹®±¸ °æÈñ´ë·Î 23 °æÈñ´ëÇб³º´¿ø

Ȩ
³»°¡ ¾Ë°íÀÖ´Â ¸íÀǸ¦ ÃßÃµÇØÁÖ¼¼¿ä